Molecular Evolution of Severe Acute Respiratory Syndrome Coronavirus 2: Hazardous and More Hazardous Strains Behind the Coronavirus Disease 2019 Pandemic and Their Targeting by Drugs and Vaccines

被引:2
作者
Tuli, Hardeep Singh [1 ]
Sak, Katrin [2 ]
Aggarwal, Poonam [3 ]
Iqubal, Ashif [4 ]
Upadhaya, Sushil K. [1 ]
Kaur, Jagjit [5 ]
Kaur, Ginpreet [6 ]
Aggarwal, Diwakar [1 ]
机构
[1] Maharishi Markandeshwar Deemed Univ, Dept Biotechnol, Mullana, India
[2] Nongovt Org NGO Praeventio, Tartu, Estonia
[3] Natl Canc Inst Frederick, Basic Res Lab, Ctr Canc Res, NIH, Frederick, MD USA
[4] Jamia Hamdard Deemed Univ, Sch Pharmaceut Educ & Res, Dept Pharmacol, Delhi, India
[5] Univ New South Wales, Fac Engn, ARC Ctr Excellence Nanoscale BioPhoton CNBP, Grad Sch Biomed Engn, Sydney, NSW, Australia
[6] Narsee Monjee Inst Management Studies SVKMS NMIMS, Shri Vile Parle Kelavani Mandal, Shobhaben Pratapbhai Patel Sch Pharm & Technol Ma, Mumbai, Maharashtra, India
关键词
COVID pandemic; variants; molecular evolution; therapeutics; vaccination; COVID-19; SARS-COV-2; REMDESIVIR; MUTATIONS; DEXAMETHASONE; REPLICATION; BARICITINIB; PROTEASE; RECEPTOR; VARIANT;
D O I
10.3389/fcimb.2021.763687
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Within almost the last 2 years, the world has been shaken by the coronavirus disease 2019 (COVID-19) pandemic, which has affected the lives of all people. With nearly 4.92 million deaths by October 19, 2021, and serious health damages in millions of people, COVID-19 has been the most serious global challenge after the Second World War. Besides lost lives and long-term health problems, devastating impact on economics, education, and culture will probably leave a lasting impression on the future. Therefore, the actual extent of losses will become obvious only after years. Moreover, despite the availability of different vaccines and vaccination programs, it is still impossible to forecast what the next steps of the virus are or how near we are to the end of the pandemic. In this article, the route of molecular evolution of the coronavirus severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is thoroughly compiled, highlighting the changes that the virus has undergone during the last 2 years and discussing the approaches that the medical community has undertaken in the fight against virus-induced damages.
引用
收藏
页数:13
相关论文
共 137 条
[1]   Implications of SARS-CoV-2 genetic diversity and mutations on pathogenicity of the COVID-19 and biomedical interventions [J].
Abdullahi, Idris N. ;
Emeribe, Anthony U. ;
Ajayi, Onaoluwa A. ;
Oderinde, Bamidele S. ;
Amadu, Dele O. ;
Osuji, Ahaneku I. .
JOURNAL OF TAIBAH UNIVERSITY MEDICAL SCIENCES, 2020, 15 (04) :258-264
[2]  
Adedokun Kamoru A, 2021, J Clin Transl Res, V7, P127
[3]   Pan-India novel coronavirus SARS-CoV-2 genomics and global diversity analysis in spike protein [J].
Alai, Shweta ;
Gujar, Nidhi ;
Joshi, Manali ;
Gautam, Manish ;
Gairola, Sunil .
HELIYON, 2021, 7 (03)
[4]   Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine [J].
Baden, Lindsey R. ;
El Sahly, Hana M. ;
Essink, Brandon ;
Kotloff, Karen ;
Frey, Sharon ;
Novak, Rick ;
Diemert, David ;
Spector, Stephen A. ;
Rouphael, Nadine ;
Creech, C. Buddy ;
McGettigan, John ;
Khetan, Shishir ;
Segall, Nathan ;
Solis, Joel ;
Brosz, Adam ;
Fierro, Carlos ;
Schwartz, Howard ;
Neuzil, Kathleen ;
Corey, Larry ;
Gilbert, Peter ;
Janes, Holly ;
Follmann, Dean ;
Marovich, Mary ;
Mascola, John ;
Polakowski, Laura ;
Ledgerwood, Julie ;
Graham, Barney S. ;
Bennett, Hamilton ;
Pajon, Rolando ;
Knightly, Conor ;
Leav, Brett ;
Deng, Weiping ;
Zhou, Honghong ;
Han, Shu ;
Ivarsson, Melanie ;
Miller, Jacqueline ;
Zaks, Tal .
NEW ENGLAND JOURNAL OF MEDICINE, 2021, 384 (05) :403-416
[5]   SARS-CoV-2 viral spike G614 mutation exhibits higher case fatality rate [J].
Becerra-Flores, Manuel ;
Cardozo, Timothy .
INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2020, 74 (08)
[6]   Observations on the use of Bruton's tyrosine kinase inhibitors in SAR-CoV-2 and cancer [J].
Benner, Brooke ;
Carson, William E. .
JOURNAL OF HEMATOLOGY & ONCOLOGY, 2021, 14 (01)
[7]   Effectiveness of Covid-19 Vaccines against the B.1.617.2 (Delta) Variant [J].
Bernal, Jamie Lopez ;
Andrews, Nick ;
Gower, Charlotte ;
Gallagher, Eileen ;
Simmons, Ruth ;
Thelwall, Simon ;
Stowe, Julia ;
Tessier, Elise ;
Groves, Natalie ;
Dabrera, Gavin ;
Myers, Richard ;
Campbell, Colin N. J. ;
Amirthalingam, Gayatri ;
Edmunds, Matt ;
Zambon, Maria ;
Brown, Kevin E. ;
Hopkins, Susan ;
Chand, Meera ;
Ramsay, Mary .
NEW ENGLAND JOURNAL OF MEDICINE, 2021, 385 (07) :585-594
[8]   Effectiveness of the Pfizer-BioNTech and Oxford-AstraZeneca vaccines on covid-19 related symptoms, hospital admissions, and mortality in older adults in England: test negative case-control study [J].
Bernal, Jamie Lopez ;
Andrews, Nick ;
Gower, Charlotte ;
Robertson, Chris ;
Stowe, Julia ;
Tessier, Elise ;
Simmons, Ruth ;
Cottrell, Simon ;
Roberts, Richard ;
O'Doherty, Mark ;
Brown, Kevin ;
Cameron, Claire ;
Stockton, Diane ;
McMenamin, Jim ;
Ramsay, Mary .
BMJ-BRITISH MEDICAL JOURNAL, 2021, 373
[9]  
Biotech B., 2021, BHARAT BIOTECH CONCL, P3
[10]   Interferon β-1a (IFNβ-1a) in COVID-19 patients (INTERCOP): study protocol for a randomized controlled trial [J].
Bosi, Emanuele ;
Bosi, Carlo ;
Querini, Patrizia Rovere ;
Mancini, Nicasio ;
Calori, Giliola ;
Ruggeri, Annalisa ;
Canzonieri, Cecilia ;
Callegaro, Luciano ;
Clementi, Massimo ;
De Cobelli, Francesco ;
Filippi, Massimo ;
Bregni, Marco .
TRIALS, 2020, 21 (01)